Cover Image
市場調查報告書

移植診斷的全球市場:2016∼2020年

Global Transplant Diagnostics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 358419
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
移植診斷的全球市場:2016∼2020年 Global Transplant Diagnostics Market 2016-2020
出版日期: 2016年05月20日 內容資訊: 英文 81 Pages
簡介

移植是為了恢復損傷的功能,轉移捐贈者的細胞、組織,或是內臟器官給接收者,捐贈者和接收者的細胞、組織、內臟器官必須適合,不然會導致移植的排斥反應。全球移植診斷市場,預計2016∼2020年以年複合成長率6.63%擴大。

本報告提供全球移植診斷市場相關調查,市場現狀及成長預測,市場課題,各地區趨勢,以及主要供應商簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析
  • 各分子化驗世界的移植診斷市場
  • 各非分子化驗世界的移植診斷市場

第6章 各篩檢市場區隔

  • 移植前診斷
  • 移植後診斷

第7章 各產品市場區隔

  • 試劑及消耗品
  • 設備

第8章 各終端用戶市場區隔

第9章 各用途市場市場區隔

  • 幹細胞移植
  • 器官移植

第10章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 推動市場的要素

第12章 促進要素的影響

第13章 市場課題

第14章 促進要素與課題的影響

第15章 市場趨勢

第16章 供應商環境

  • 競爭模式

第17章 主要供應商分析

  • Bio-Rad Laboratories
  • CareDx
  • Illumina
  • Immucor
  • Linkage Biosciences
  • Thermo Fisher Scientific
  • 其他值得注意的供應商

第18章 附錄

第19章 關於Technavio

圖表

目錄
Product Code: IRTNTR9483

About the Transplant Diagnostics Market

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.

Technavio's analysts forecast the global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global transplant diagnostics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of molecular and non-molecular assays. We also consider the revenue generated from pre- and post-transplant diagnostic products and accessories.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Transplant Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bio-Rad Laboratories
  • CareDx
  • Illumina
  • Immucor
  • Linkage Biosciences
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Abbott Laboratories
  • Becton
  • Dickinson
  • Danaher
  • F. Hoffmann-La Roche
  • HistoGenetics
  • Ortho Clinical Diagnostics
  • Oxford Immunotec
  • Qiagen
  • Siemens
  • Sigma-Aldrich
  • Tosoh Bioscience

Market driver

  • Public awareness of organ donation
  • For a full, detailed list, view our report

Market challenge

  • Limited technical expertise
  • For a full, detailed list, view our report

Market trend

  • Product approvals and launches
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis
  • Global transplant diagnostics market by molecular assays
  • Global transplant diagnostics market by non-molecular assays

PART 06: Market segmentation by screening

  • Pre-transplant diagnostics
  • Post-transplant diagnostics

PART 07: Market segmentation by product

  • Reagents and consumables
  • Instruments

PART 08: Market segmentation by end-user

PART 09: Market segmentation by application

  • Stem cell transplantation
  • Organ transplantation

PART 10: Geographical segmentation

  • Transplant diagnostics market in Americas
  • Transplant diagnostics market in EMEA
  • Transplant diagnostics market in APAC

PART 11: Market drivers

  • Prevalence of chronic diseases
  • Public awareness of organ donation
  • Growth opportunities in emerging markets

PART 12: Impact of drivers

PART 13: Market challenges

  • Unfavorable reimbursement scenario
  • Limited technical expertise
  • High cost of transplant diagnostics

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Advances in technology
  • Government initiatives
  • Product approvals and launches
  • Increase in M&A

PART 16: Vendor landscape

  • Competitive scenario

PART 17: Major vendors

  • Bio-Rad Laboratories
  • CareDx
  • Illumina
  • Immucor
  • Linkage Biosciences
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Types of HLA testing used to determine compatibility
  • Exhibit 03: Global transplant diagnostics market 2015-2020 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global transplant diagnostics market segmentation by technique
  • Exhibit 06: Global transplant diagnostics market segmentation by technique 2015
  • Exhibit 07: Global transplant diagnostics market segmentation by technique 2020
  • Exhibit 08: PCR techniques: Advantages and disadvantages
  • Exhibit 09: Global transplant diagnostics market by molecular assays 2015-2020 ($ millions)
  • Exhibit 10: Global transplant diagnostics market by non-molecular assays 2015-2020 ($ millions)
  • Exhibit 11: Global transplant diagnostics market segmentation by screening 2015
  • Exhibit 12: Global transplant diagnostics market segmentation by screening 2020
  • Exhibit 13: Overview of pre- and post-transplant diagnosis
  • Exhibit 14: Global pre-transplant diagnostics market 2015-2020 ($ millions)
  • Exhibit 15: Global post-transplant diagnostics market 2015-2020 ($ millions)
  • Exhibit 16: Some reagents, consumables, and instruments available commercially
  • Exhibit 17: Global transplant diagnostics market by product 2015
  • Exhibit 18: Global transplant diagnostics market by product 2020
  • Exhibit 19: Global transplant diagnostics market segmentation by end-user 2015
  • Exhibit 20: Global transplant diagnostics market segmentation by end-user 2020
  • Exhibit 21: Global transplant diagnostics market segmentation by application
  • Exhibit 22: Global transplant diagnostics market segmentation by organ transplantation 2015
  • Exhibit 23: Global transplant diagnostics market segmentation by organ transplantation 2020
  • Exhibit 24: Deceased donors for different organs 2015
  • Exhibit 25: Living donors for different organs 2015
  • Exhibit 26: Global transplant diagnostics market segmentation by geography 2015
  • Exhibit 27: Global transplant diagnostics market segmentation by geography 2020
  • Exhibit 28: Global transplant diagnostics market segmentation by geography 2015-2020
  • Exhibit 29: Transplant diagnostics market in Americas 2015-2020 ($ millions)
  • Exhibit 30: Transplant diagnostics market in EMEA 2015-2020 ($ millions)
  • Exhibit 31: Transplant diagnostics market in APAC 2015-2020 ($ millions)
  • Exhibit 32: Impact of drivers
  • Exhibit 33: Price of sequencers of different companies
  • Exhibit 34: Impact of drivers and challenges
  • Exhibit 35: Bio-Rad Laboratories: Product portfolio
  • Exhibit 36: Bio-Rad Laboratories: Revenue of clinical diagnostics segment 2013-2015 ($ billions)
  • Exhibit 37: Bio-Rad Laboratories: Key takeaways
  • Exhibit 38: CareDx: Product portfolio
  • Exhibit 39: CareDx: AlloSure clinical studies
  • Exhibit 40: CareDx: Key takeaways
  • Exhibit 41: Illumina: Product portfolio
  • Exhibit 42: Illumina: Key takeaways
  • Exhibit 43: Immucor: Product portfolio
  • Exhibit 44: Immucor: Revenue of transplant and molecular segment 2013-2015 ($ millions)
  • Exhibit 45: Immucor: Key takeaways
  • Exhibit 46: Linkage Biosciences: Product portfolio
  • Exhibit 47: Linkage Biosciences: Key takeaways
  • Exhibit 48: Thermo Fisher Scientific: Product portfolio
  • Exhibit 49: Thermo Fisher Scientific: Revenue of specialty diagnostics segment 2013-2015 ($ billions)
  • Exhibit 50: Thermo Fisher Scientific: Key takeaways
  • Exhibit 51: Other prominent vendors
Back to Top